Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
4(80%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

5

all time

Status Distribution
Active(4)
Completed(1)

Detailed Status

Active, not recruiting2
Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
4
Success Rate
100.0%

Trials by Status

active_not_recruiting240%
completed120%
recruiting240%

Recent Activity

4 active trials
Showing 5 of 5
recruiting

Trifecta-Kidney cfDNA-MMDx Study

NCT04239703
recruiting

Trifecta-Heart cfDNA-MMDx Study

NCT04707872
active_not_recruiting

LAMBDA 002 (Lung Registry) Study

NCT05170425
completed

Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation

NCT05309382
active_not_recruiting

The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)

NCT04091984

Clinical Trials (5)

Showing 5 of 5 trials
NCT04239703

Trifecta-Kidney cfDNA-MMDx Study

Recruiting
NCT04707872

Trifecta-Heart cfDNA-MMDx Study

Recruiting
NCT05170425

LAMBDA 002 (Lung Registry) Study

Active Not Recruiting
NCT05309382

Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation

Completed
NCT04091984

The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)

Active Not Recruiting

All 5 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5